Results 161 to 170 of about 17,014 (180)
Some of the next articles are maybe not open access.
Psychopharmacology, 1993
Narcolepsy is currently treated with anti-depressants to control REM-related symptoms such as cataplexy and with amphetamine-like stimulants for the management of sleepiness. Both stimulant and antidepressant drugs presynaptically enhance monoaminergic transmission but both classes of compounds lack pharmacological specificity.
E, Mignot +5 more
openaire +2 more sources
Narcolepsy is currently treated with anti-depressants to control REM-related symptoms such as cataplexy and with amphetamine-like stimulants for the management of sleepiness. Both stimulant and antidepressant drugs presynaptically enhance monoaminergic transmission but both classes of compounds lack pharmacological specificity.
E, Mignot +5 more
openaire +2 more sources
Brain Research, 1987
Sertraline, a potent and selective inhibitor of serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]dihydroalprenolol ([3H]DHA) was reduced in cortex layers IV-VI.
W F, Byerley +5 more
openaire +2 more sources
Sertraline, a potent and selective inhibitor of serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]dihydroalprenolol ([3H]DHA) was reduced in cortex layers IV-VI.
W F, Byerley +5 more
openaire +2 more sources
Inhibitors of the Uptake of Norepinephrine by the Adrenergic Nerves in Rabbit Aorta
2015R. A. Maxwell +3 more
openaire +1 more source
The Journal of Pharmacology and Experimental Therapeutics, 1970
R E, Maxwell +4 more
openaire +2 more sources
R E, Maxwell +4 more
openaire +2 more sources
Journal of Allergy and Clinical Immunology: in Practice, 2020
Manshi Li, Martin A Smith, David M Lang
exaly
Manshi Li, Martin A Smith, David M Lang
exaly

